HEMERA-Lab

Featured projects

Competitive funding

Identification of key molecules with antifibrotic effects from the alveolar type II cell secretome for the development of new therapies for idiopathic pulmonary fibrosis

Principal investigator
Anna Serrano Mollar, Pedro Melgar-Lesmes
Funder
La Marató de 3Cat
Reference
202535-30
Period
2026 – 2029

Treatment of metabolic liver disease using gold nanoenzymes with multicatalytic activity

Principal investigator
Gregori Casals Mercadal
Funder
Instituto de Salud Carlos III (ISCIII)
Reference
PI24/00688
Period
2025 – 2027

CRINGENES – A new dimension in newborn screening: pilot study of integrated genomic newborn screening

Principal investigator
Judit Garcia-Villoria
Funder
Instituto de Salud Carlos III (ISCIII)
Reference
—
Period
2025 – 2026

Function and therapeutic potential of RNA helicases and miR-122a-5p in liver regeneration and cancer

Principal investigator
Manuel Morales-Ruiz
Funder
Agencia Estatal de Investigación (AEI)
Reference
PID2022-138243OB-I00
Period
2024 – 2026

Novel industrially scalable nanotherapies to treat portal hypertension and liver fibrosis in humans

Principal investigator
Wladimiro Jiménez Povedano
Funder
Agencia Estatal de Investigación (AEI)
Reference
—
Period
2023 – 2026

ENGILIVE – Novel immunomodulatory engineered therapeutic strategies for liver diseases: matrix-embedded endothelial cells and macrophage-targeted dendrimer nanoparticles

Principal investigator
Pedro Melgar-Lesmes
Funder
Ministerio de Ciencia, Innovación y Universidades
Reference
PID2021-123426OB-I00
Period
2022 – 2025

FXPAC – Fragile X premutation associated conditions: clinical characterisation and signature analysis

Principal investigator
Laia Rodríguez-Revenga
Funder
Instituto de Salud Carlos III (ISCIII)
Reference
PI21/01085
Period
2022 – 2024

Main funders

  • Instituto de Salud Carlos III (ISCIII)
  • Agencia Estatal de Investigación (AEI)
  • Ministerio de Ciencia, Innovación y Universidades
  • La Marató de 3Cat
  • AGAUR – Generalitat de Catalunya
  • CIBEREHD
  • EF Clif
  • Programa Beatriu de Pinós
  • Ferring